Combining ulinastatin with TIENAM improves the outcome of sepsis induced by cecal ligation and puncture in mice by reducing inflammation and regulating immune responses
Authors:
- 19 August 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 141, 112927
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Projects of Fujian Province (2021\u202FJ01204)
- National Aerospace Science Foundation of China
- National Natural Science Foundation of China (82,202,906, 81803547, 81901243)
- Fujian Provincial Health Technology Project (2021\u202FN3005)
This publication has 48 references indexed in Scilit:
- Protective effects of DcR3-SUMO on lipopolysaccharide-induced inflammatory cells and septic miceInternational Journal of Biological Macromolecules, 2024
- Persistent inflammation, immunosuppression, and catabolism syndrome (PICS): a review of definitions, potential therapies, and research prioritiesBritish Journal of Anaesthesia, 2024
- Protective effect of Ulinastatin on acute lung injury in diabetic sepsis ratsInternational Immunopharmacology, 2022
- The immunology of sepsisImmunity, 2021
- A probabilistic model for the prediction of intra-abdominal infection after colorectal surgeryInternational Journal of Colorectal Disease, 2021
- Imipenem alters systemic and liver inflammatory responses in CLP- induced sepsis mice in a dose-dependent mannerInternational Immunopharmacology, 2021
- Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial InfectionsDrugs, 2021
- Neonatal Early-Onset Sepsis Calculator and Antibiotic TherapyJAMA Pediatrics, 2020
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Ulinastatin- and thymosin α1-based immunomodulatory strategy for sepsis: A meta-analysisInternational Immunopharmacology, 2015